Spectrum Pharma (SPPI) Files $250M Mixed Shelf
Spectrum Pharmaceuticals (NASDAQ: SPPI) filed a registration with the U.S. Securities and Exchange Commission today to sell, from time to time, up to $250 million in Debt Securities, Preferred Stock, Common Stock, Warrants, Units, or any combination thereof.
Create E-mail AlertRelated Categories
Equity OfferingsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
